Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1986 1
1988 1
1989 1
1990 2
1991 1
1993 1
2002 1
2003 1
2004 6
2005 4
2006 7
2007 6
2008 6
2009 1
2010 7
2011 6
2012 9
2013 9
2014 12
2015 11
2016 9
2017 11
2018 9
2019 15
2020 15
2021 22
2022 19
2023 12
2024 14
2025 13

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

187 results

Results by year

Filters applied: . Clear all
Page 1
Preclinical Efficacy and Safety of a Human Embryonic Stem Cell-Derived Midbrain Dopamine Progenitor Product, MSK-DA01.
Piao J, Zabierowski S, Dubose BN, Hill EJ, Navare M, Claros N, Rosen S, Ramnarine K, Horn C, Fredrickson C, Wong K, Safford B, Kriks S, El Maarouf A, Rutishauser U, Henchcliffe C, Wang Y, Riviere I, Mann S, Bermudez V, Irion S, Studer L, Tomishima M, Tabar V. Piao J, et al. Among authors: el maarouf a. Cell Stem Cell. 2021 Feb 4;28(2):217-229.e7. doi: 10.1016/j.stem.2021.01.004. Cell Stem Cell. 2021. PMID: 33545080 Free PMC article.
High-Dose Vitamin D in Clinically Isolated Syndrome Typical of Multiple Sclerosis: The D-Lay MS Randomized Clinical Trial.
Thouvenot E, Laplaud D, Lebrun-Frenay C, Derache N, Le Page E, Maillart E, Froment-Tilikete C, Castelnovo G, Casez O, Coustans M, Guennoc AM, Heinzlef O, Magy L, Nifle C, Ayrignac X, Fromont A, Gaillard N, Caucheteux N, Patry I, De Sèze J, Deschamps R, Clavelou P, Biotti D, Edan G, Camu W, Agherbi H, Renard D, Demattei C, Fabbro-Peray P, Mura T, Rival M; D-Lay MS Investigators. Thouvenot E, et al. JAMA. 2025 Apr 22;333(16):1413-1422. doi: 10.1001/jama.2025.1604. JAMA. 2025. PMID: 40063041 Free PMC article. Clinical Trial.
Brain atrophy patterns in anti-IgLON5 disease.
Yogeshwar SM, Bartels F, Grüter T, Muñiz-Castrillo S, Picard G, Crijnen YS, Bernard E, Heidbreder A, Zekeridou A, Ringelstein M, Kraft A, Kovac S, Wandinger KP, de Vries JM, Boon AJW, Veenbergen S, Geis C, Penner L, Melzer N, Leypoldt F, Blaabjerg M, Pittock SJ, Gaig C, Sabater L, Santamaria J, Graus F, Dalmau J, Prüss H, Höftberger R, Schreiner B, McKeon A, Lewerenz J, Irani S, Mignot E, Titulaer MJ, Ayzenberg I, Honnorat J, Finke C; IgLON5 Imaging Consortium. Yogeshwar SM, et al. Brain. 2025 Jul 12:awaf256. doi: 10.1093/brain/awaf256. Online ahead of print. Brain. 2025. PMID: 40650880
Extended-interval dosing of rituximab/ocrelizumab is associated with a reduced decrease in IgG levels in multiple sclerosis.
Rigollet C, Freeman SA, Perriguey M, Stellmann JP, Graille-Avy L, Lafontaine JC, Lemarchant B, Alberto T, Demortière S, Boutiere C, Rico A, Hilézian F, Durozard P, Pelletier J, Maarouf A, Zéphir H, Audoin B. Rigollet C, et al. Among authors: maarouf a. Neurotherapeutics. 2025 Apr;22(3):e00554. doi: 10.1016/j.neurot.2025.e00554. Epub 2025 Feb 20. Neurotherapeutics. 2025. PMID: 39979176 Free PMC article.
Fluorescein Angiography as a Surrogate Marker of Disease Activity in Susac Syndrome.
Guttieres L, Vannelli L, Demortiere S, Perriguey M, Elziere M, Durozard P, Boutiere C, Rico A, Hilezian F, Stellmann JP, Pelletier J, Maarouf A, Stolowy N, Audoin B. Guttieres L, et al. Among authors: maarouf a. Neurol Neuroimmunol Neuroinflamm. 2025 Mar;12(2):e200379. doi: 10.1212/NXI.0000000000200379. Epub 2025 Feb 5. Neurol Neuroimmunol Neuroinflamm. 2025. PMID: 39908480 Free PMC article.
Risk Factors and Time to Clinical Symptoms of Multiple Sclerosis Among Patients With Radiologically Isolated Syndrome.
Lebrun-Frénay C, Rollot F, Mondot L, Zephir H, Louapre C, Le Page E, Durand-Dubief F, Labauge P, Bensa C, Thouvenot E, Laplaud D, de Seze J, Ciron J, Bourre B, Cabre P, Casez O, Ruet A, Mathey G, Berger E, Moreau T, Al Khedr A, Derache N, Clavelou P, Guennoc AM, Créange A, Neau JP, Tourbah A, Camdessanché JP, Maarouf A, Callier C, Vermersch P, Kantarci O, Siva A, Azevedo C, Makhani N, Cohen M, Pelletier D, Okuda D, Vukusic S; RISC, SFSEP, and OFSEP Investigators. Lebrun-Frénay C, et al. Among authors: maarouf a. JAMA Netw Open. 2021 Oct 1;4(10):e2128271. doi: 10.1001/jamanetworkopen.2021.28271. JAMA Netw Open. 2021. PMID: 34633424 Free PMC article.
Testosterone therapy reduces insulin resistance in men with adult-onset testosterone deficiency and metabolic syndrome. Results from the Moscow Study, a randomized controlled trial with an open-label phase.
Tishova Y, Kalinchenko S, Mskhalaya G, Hackett G, Livingston M, König C, Strange R, Zitzmann M, Mann A, Maarouf A, Ramachandran S. Tishova Y, et al. Among authors: maarouf a. Diabetes Obes Metab. 2024 Jun;26(6):2147-2157. doi: 10.1111/dom.15520. Epub 2024 Mar 3. Diabetes Obes Metab. 2024. PMID: 38433502 Clinical Trial.
RAD51 regulates eukaryotic chromatin motions in the absence of DNA damage.
Maarouf A, Iqbal F, Sanaullah S, Locatelli M, Atanasiu AT, Kolbin D, Hommais C, Mühlemann JK, Bonin K, Bloom K, Liu J, Vidi PA. Maarouf A, et al. Mol Biol Cell. 2024 Nov 1;35(11):ar136. doi: 10.1091/mbc.E24-04-0188. Epub 2024 Sep 18. Mol Biol Cell. 2024. PMID: 39292916 Free PMC article.
187 results